Bumrungrad Hospital Public Company Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BUGDF research report →
Companywww.bumrungrad.com
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers.
- CEO
- Artirat Charukitpipat
- IPO
- 2010
- Employees
- 4,506
- HQ
- Bangkok, TH
Price Chart
Valuation
- Market Cap
- $3.78B
- P/E
- 18.22
- P/S
- 5.46
- P/B
- 4.26
- EV/EBITDA
- 13.07
- Div Yield
- 6.34%
Profitability
- Gross Margin
- 51.97%
- Op Margin
- 34.93%
- Net Margin
- 29.96%
- ROE
- 25.10%
- ROIC
- 20.90%
Growth & Income
- Revenue
- $25.11B · -2.35%
- Net Income
- $7.51B · -3.46%
- EPS
- $9.46 · -3.27%
- Op Income
- $8.77B
- FCF YoY
- -10.31%
Performance & Tape
- 52W High
- $6.31
- 52W Low
- $3.95
- 50D MA
- $4.94
- 200D MA
- $5.01
- Beta
- 0.24
- Avg Volume
- 54
Get TickerSpark's AI analysis on BUGDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BUGDF Coverage
We haven't published any research on BUGDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BUGDF Report →